FRONTIER CAPITAL MANAGEMENT CO LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 114 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
FRONTIER CAPITAL MANAGEMENT CO LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$3,435,000
+20.4%
629,154
-0.5%
0.04%
+21.2%
Q2 2022$2,853,000
-69.7%
632,506
-50.6%
0.03%
-61.2%
Q1 2022$9,428,000
-13.0%
1,279,295
-24.1%
0.08%
-1.2%
Q4 2021$10,837,000
+68.9%
1,685,405
+52.9%
0.09%
+72.0%
Q3 2021$6,416,000
-58.2%
1,102,427
-26.0%
0.05%
-55.8%
Q2 2021$15,366,000
+19.6%
1,488,939
+21.9%
0.11%
+16.5%
Q1 2021$12,852,000
-73.5%
1,221,627
-60.9%
0.10%
-72.9%
Q4 2020$48,415,000
-10.5%
3,127,571
-15.6%
0.36%
-24.2%
Q3 2020$54,075,000
+2.3%
3,703,786
+32.7%
0.47%
+0.9%
Q2 2020$52,852,000
+49.6%
2,790,501
+51.7%
0.47%
+17.9%
Q1 2020$35,336,000
+80.9%
1,839,440
+80.5%
0.40%
+175.7%
Q4 2019$19,537,000
+14.4%
1,019,138
-42.6%
0.14%
+7.5%
Q3 2019$17,084,000
+317.7%
1,775,865
+160.1%
0.13%
+332.3%
Q2 2019$4,090,000
+2.5%
682,853
-0.1%
0.03%
+10.7%
Q1 2019$3,991,000
+156.8%
683,363
+311.9%
0.03%
+115.4%
Q4 2018$1,554,000
-55.4%
165,899
-18.9%
0.01%
-40.9%
Q3 2018$3,484,000
-33.2%
204,556
-33.4%
0.02%
-40.5%
Q2 2018$5,217,000307,0350.04%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,180,700$137,941,00010.27%
Palo Alto Investors LP 4,299,901$82,601,0006.92%
Fairmount Funds Management LLC 562,351$10,803,0006.55%
Avoro Capital Advisors LLC 7,000,000$134,470,0004.54%
Pinz Capital Management, LP 8,820$1,694,0004.44%
Birchview Capital, LP 148,000$2,843,0002.52%
Elk Creek Partners, LLC 699,951$13,446,0002.31%
Parkman Healthcare Partners LLC 215,802$4,146,0001.92%
EAM Global Investors LLC 136,402$2,620,0001.53%
SPHERA FUNDS MANAGEMENT LTD. 550,000$10,566,0001.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders